EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis
Lechen Li(Harbin Medical University), Kathleen Kelly(The Ohio State University), Keith H. Jansson(National Cancer Institute), Ross Lake(National Cancer Institute), Simeng Wang(First Affiliated Hospital of Xi'an Jiaotong University), Órla Casey(Cancer Trials Ireland), Amir H. Ameri(National Cancer Institute), Lei Fang(Jiujiang University), Supreet Agarwal(University of Iowa), Aian Neil Alilin(National Cancer Institute), Qi Yang(Leidos (United States)), Wanhai Xu(Harbin Medical University), JuanJuan Yin(National Cancer Institute), Michael L. Beshiri(National Cancer Institute)
Cited by 172
Related Papers
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
|Cell|1983|2.3k
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
|Journal for ImmunoTherapy of Cancer|2018|314
CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p
|Molecular Cancer|2019|242